摘要
目的观察病毒性心肌炎药物治疗的临床效果。方法选择病毒性心肌炎患者60例,随机分为2组,试验组30例在常规药物的基础上加用环磷酸腺苷葡胺(心酰胺)治疗;对照组30例采用复方丹参注射液,黄芪注射液和维生素C等常规药物治疗。结果试验组治愈20例,显效4例,有效3例,无效3例,总有效率为90%;对照组治愈14例,显效4例,有效3例,无效9例,总有效率为70%。结论环磷酸腺苷葡胺能进一步提高病毒性心肌炎药物治疗的临床效果。
Objective To observe the clinical results of the drug treatment of viral myocarditis. Methods Sixty patients with viral myocarditis were randomly divided into two groups： experimental group and control group with 30 cases in each group. The control group was given compound Danshen injection, Astragalus injection, vitamin C and other conventional drug treatment, The experimental group was given meglumine cyclic adenosine monophosphate （heart amide） in the basis of conventional drug treatment. Results In the experimental group, 20 patients were cured, 4 cases were markedly effective, 3 cases were effective and 3 cases were ineffective, the total effective rate was 90%. As for the control group,14 cases were cured, 4 cases were markedly effective,3 cases were effective, and 9 cases were ineffective with the total effective rate of 70%. Conclusion cAMP meglumine can further improve the clinical results of the drug treatment of viral myocarditis.
出处
《河北医科大学学报》
CAS
2011年第3期263-265,共3页
Journal of Hebei Medical University
关键词
心肌炎
药物疗法
治疗结果
myocarditis
drug therapy
treatment outcome
